192. コケイン症候群 Cockayne syndrome Clinical trials / Disease details

臨床試験数 : 4 / 薬物数 : 7 - (DrugBank : 3) / 標的遺伝子数 : 1 - 標的パスウェイ数 : 51

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR1900026719	2019-11-01	2019-10-19	Clinical study for combined application of vitamin C and quercetin in the treatment of Cockayne's sy ...	Clinical study for combined application of vitamin C and quercetin in the treatment of Cockayne's sy ...	Cockayne's syndrome	test group:Vitamin C and Quercetin;	The First Medical Center of PLA General Hospital	NULL	Pending	6	13	Both	test group:20;		China
2	NCT03016715 (ClinicalTrials.gov)	May 2016	9/1/2017	Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study	A Prospective, Double-Blind, Cross-Over, Pilot Study to Assess Safety and Efficacy of Topical Siroli ...	Epidermolysis Bullosa Simplex;Epidermolysis Bullosa Simplex Kobner;Weber-Cockayne Syndrome	Drug: Sirolimus 2%;Drug: Vehicle	Premier Specialists, Australia	NULL	Recruiting	5 Years	N/A	All	8	Phase 2	Australia
3	NCT02960997 (ClinicalTrials.gov)	May 2016	15/6/2016	Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study	A Prospective, Double-Blind, Cross-Over, Pilot Study to Assess Safety and Efficacy of Topical Siroli ...	Epidermolysis Bullosa Simplex;Epidermolysis Bullosa Simplex Kobner;Weber-Cockayne Syndrome	Drug: Sirolimus , 2%;Drug: Vehicle	Stanford University	NULL	Active, not recruiting	4 Years	N/A	All	8	Phase 2	United States
4	NCT01142154 (ClinicalTrials.gov)	June 2010	20/5/2010	Pharmacokinetics and Safety Study of Single and Multiple Oral Doses Prodarsan™ in Patients With Cock ...	A Phase I/II Crossover Study To Evaluate and Compare the Pharmacokinetics of a Single IV Dose of D-M ...	Cockayne Syndrome	Drug: Prodarsan	DNage B.V.	NULL	Completed	2 Years	10 Years	Both	5	Phase 1/Phase 2	United States

First Previous1Next Last